Fracture patterns and petrophysical properties of carbonates undergoing regional folding : A case study from Kurdistan, N Iraq

Acknowledgements The authors thank the Ministry of Natural Resources in Iraqi Kurdistan Region for permission to publish this paper. Gulf Keystone Petroleum Ltd. and HKN Energy Ltd. are acknowledged for providing the subsurface datasets. Great thanks to Colin Taylor at the University of Aberdeen for his assistance in the laboratory work. Thoughtful reviews by two anonymous referees improved the clarity of the paper. Graham Banks is thanked for his helpful and constructive review on a late version of the manuscript, which has significantly improved this paper.Peer reviewedPostprin

The effect of diagenesis and facies distribution on reservoir quality in the Permian sandstones of the Toolachee gas field, southern Cooper Basin, South Australia

Thesis (M.S.) -- University of Adelaide, Dept. of Geology and Geophysics, 199

From hot to cold - The temperature dependence on rock deformation processes : An introduction

Acknowledgements We thank Bill Dunne for his work as Journal of Structural Geology overseeing editor, and to all the reviewers of manuscripts submitted to this special issue. We gratefully acknowledge Richard D. Law, Paul D. Bons, Albert Griera and Maria-Gema Llorens for reviewing this article prior to submission. The programme, abstract and field excursion guides for the DRT-2017 Inverness conference are available at: https://www.abdn.ac.uk/geosciences/events/downloads-1112.php.Peer reviewedPostprin

Functional MRI and the Wada test provide complementary information for predicting post-operative seizure control

AbstractPrediction of post-surgical seizure relief and potential cognitive deficits secondary to anterior temporal lobectomy (ATL) are important to pre-surgical planning. Although the intracarotid amobarbital test (IAT) is predictive of post-ATL seizure outcome, development of non-invasive and more precise means for determining post-ATL seizure relief are needed. We previously reported on a technique utilizing functional MRI (fMRI) to evaluate the relative functional adequacy of mesial temporal lobe structures in preparation for ATL . In the present study, we report follow-up outcome data on eight temporal lobe epilepsy (TLE) patients 1-year post-ATL who were evaluated pre-surgically using IAT and fMRI. Functional memory lateralization using fMRI predicted post-ATL seizure outcome as effectively as the IAT. In general, asymmetry of functional mTL activation favouring the non-epileptic hemisphere was associated with seizure-free status at 1-year follow-up. Moreover, when combined, fMRI and IAT provided complementary data that resulted in improved prediction of post-operative seizure control compared with either procedure alone

Multiple episodes of sand injection leading to accumulation and leakage of hydrocarbons along the San Andreas/San Gregorio fault system, California

Acknowledgements We acknowledge the reviews of three anonymous referees and are also very grateful to Andrew Hurst and David Iacopini for their critical comments of an earlier version of the paper. We also wish to thank Denis Bureau and Antonella Gatto for their support in the field.Peer reviewedPostprin

Issues raised developing AQuRate (an authoring tool that uses the question and test interoperability version 2 specification)

The IMS Question & Test Interoperability (QTI) specification has existed for many years, and there are a few tools for authoring questions in early versions of the specification. However, the new QTIv2 specification was unsupported in any existing authoring environment. The AQuRate project was funded by JISC’s capital project program to fill this gap. AQuRate is one of three JISC projects, which together aimed to support the whole e-assessment process, from authoring (AQuRate at Kingston University) to storage (Minibix at Cambridge) and finally to a delivery/assessment development (ASDEL at Southampton). This paper considers issues raised during the creation of the tool: data modelling, graphical user interface design, and use cases. It ends raising issues currently effecting on-going development

High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma

<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) responds to agents that inhibit vascular endothelial growth factor (VEGF) pathway. Sorafenib, a multikinase inhibitor of VEGF receptor, is effective at producing tumor responses and delaying median progression free survival in patients with cytokine refractory RCC. However, resistance to therapy develops at a median of 5 months. In an effort to increase efficacy, we studied the effects of increased sorafenib dose and intermittent scheduling in a murine RCC xenograft model.</p> <p>Methods</p> <p>Mice bearing xenografts derived from the 786-O RCC cell line were treated with sorafenib according to multiple doses and schedules: 1) Conventional dose (CD) continuous therapy; 2) high dose (HD) intermittent therapy, 3) CD intermittent therapy and 4) HD continuous therapy. Tumor diameter was measured daily. Microvessel density was assessed after 3 days to determine the early effects of therapy, and tumor perfusion was assessed serially by arterial spin labeled (ASL) MRI at day 0, 3, 7 and 10.</p> <p>Results</p> <p>Tumors that were treated with HD sorafenib exhibited slowed tumor growth as compared to CD using either schedule. HD intermittent therapy was superior to CD continous therapy, even though the total dose of sorafenib was essentially equivalent, and not significantly different than HD continuous therapy. The tumors exposed to HD sorafenib had lower microvessel density than the untreated or the CD groups. ASL MRI showed that tumor perfusion was reduced to a greater extent with the HD sorafenib at day 3 and at all time points thereafter relative to CD therapy. Further the intermittent schedule appeared to maintain RCC sensitivity to sorafenib as determined by changes in tumor perfusion.</p> <p>Conclusions</p> <p>A modification of the sorafenib dosing schedule involving higher dose intermittent treatment appeared to improve its efficacy in this xenograft model relative to conventional dosing. MRI perfusion imaging and histologic analysis suggest that this benefit is related to enhanced and protracted antiangiogenic activity. Thus, better understanding of dosing and schedule issues may lead to improved therapeutic effectiveness of VEGF directed therapy in RCC and possibly other tumors.</p

Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts

Background: Sunitinib (Su), a tyrosine kinase inhibitor of VEGFR, is effective at producing tumour response in clear cell renal cell carcinoma (cRCC), but resistance to therapy is inevitable. As COX-2 is a known mediator of tumour growth, we explored the potential benefit of COX-2 inhibition in combination with VEGFR inhibition in attempts at delaying tumour progression on Su. Methods: COX-2 expression was compared with areas of hypoxia in tumours that progressed on Su vs untreated tumours. Mice bearing human cRCC xenografts were treated with Su and the COX-2 inhibitor, celecoxib, and the effects on tumour growth were assessed. Sequential vs concurrent regimens were compared. Results: COX-2 expression was increased in cRCC xenografts in areas of tumour hypoxia. The combination of Su and celecoxib achieved longer times to tumour progression compared to treatment with either agent alone or to untreated control animals in four models. This effect was seen with concurrent but not with sequential therapy. Conclusion: COX-2 inhibition can extend the effectiveness of VEGFR inhibition. This effect is dependent on the timing of therapy. Clinical trials combining Su and COX-2 inhibitors should be considered as a means delaying time to progression on sunitinib in patients with metastatic cRCC

Three‐Dimensional Brain MRI for DBS Patients within Ultra‐Low Radiofrequency Power Limits

Background: For patients with deep brain stimulators (DBS), local absorbed radiofrequency (RF) power is unknown and is much higher than what the system estimates. We developed a comprehensive, highquality brain magnetic resonance imaging (MRI) protocol for DBS patients utilizing three-dimensional (3D) magnetic resonance sequences at very low RF power. Methods: Six patients with DBS were imaged (10 sessions) using a transmit/receive head coil at 1.5 Tesla with modified 3D sequences within ultra-low specific absorption rate (SAR) limits (0.1 W/kg) using T2, fast fluid-attenuated inversion recovery (FLAIR) and T1- weighted image contrast. Tissue signal and tissue contrast from the low-SAR images were subjectively and objectively compared with routine clinical images of six age-matched controls. Results: Low-SAR images of DBS patients demonstrated tissue contrast comparable to high-SAR images and were of diagnostic quality except for slightly reduced signal. Conclusions: Although preliminary, we demonstrated diagnostic quality brain MRI with optimized, volumetric sequences in DBS patients within very conservative RF safety guidelines offering a greater safety margin